feed,title,long_url,short_url
Benzinga,EXCLUSIVE: ChemoCentryx Plans To Start Phase 3 Avacopan Trial In Chronic Skin Disorder In 2022,https://benzinga.com/general/biotech/21/10/23300319/exclusive-chemocentryx-plans-to-start-phase-3-avacopan-trial-in-chronic-skin-disorder-in-2022,https://j.mp/3oJioQJ
Benzinga,Why Baidu Shares Are Rising,https://benzinga.com/news/21/10/23300611/why-baidu-shares-are-rising,https://j.mp/3Fw7rYE
